- AXA Strategic Ventures (ASV) adds today a new company in its Early Stage portfolio in Europe: BioBeats, a machine learning platform that delivers insights about the wellbeing of individuals in real-time.
- The funding round (£1.6m) led by White Cloud Capital with the participation of IQ Capital, will be used to implement full product delivery and commercialisation of its biometrics based, stress-relieving app, Hear and Now, for both the consumer and corporate wellness market, as well as the company’s expansion into the US market.
- The application is currently running advanced pilot programmes in major UK healthcare companies and corporates, including AXA PPP.
AXA Strategic Ventures (ASV), a global €230 million ($260 million) venture capital fund, adds today a new investment to its portfolio in Europe. BioBeats was founded in 2013 with the premise that prevention is the best approach to wellness. Using existing wearable devices and smartphones, this cloud-based programme gathers biometric information about wellbeing, learning what makes an individual tick and building a unique profile on a personal dashboard regarding sleep, activity, and stress. The software uses these insights to design a personalised coaching programme around individual wellbeing goals – helping to develop healthy responses and build mindful awareness into daily lives.
For organisations the platform can integrate with HR systems and productivity suites, delivering insights on workforce wellbeing and productivity.
“A deep understanding of employee wellness is critical to building a great global business, and BioBeats allows companies to keep a finger on the pulse of their organisations and encourage individuals to own their wellness. We are excited to receive this investment and further our geographic and product reach, commented David Plans, CEO and Co-founder at BioBeats. “It will come as no surprise but our competitive advantage is our people, coupled with the fact we have been doing this longer than anyone else, and have cracked the algorithms and understanding of the patterns of stress with the onset of disease.”
"The solutions developed by BioBeats are both innovative and improve the customer experience, with a unique focus on technology and the user. We are convinced that prevention is the best cure and that BioBeats’ approach will allow our business customers to understand employee wellness and build greater, global businesses,” said @Minh_Q_Tran, General Partner, AXA Strategic Ventures.
|
BioBeats is an adaptive media company, which builds technologies that respond to physiologic data and learn from user interaction, helping people to live more engaging, healthier lives. The company develops programmes for entertainment, consumer health and wellness, and clinical medicine. The company’s adaptive health technologies are built on a cloud-based responsive platform designed to support the management of chronic conditions and general wellness. Its latest app, Hear and Now, is available to download from the Apple App Store. |
|
The BioBeats team is based in San Francisco, London and Pisa, which allows the company to understand the nuances of healthcare in the both the US and Europe. |